# Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

Study · id `cardio:ct-nct06144125` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06144125](<https://clinicaltrials.gov/study/NCT06144125>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06144125

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06144125. Randomized; double masking; primary purpose treatment. Start 2026-03-27 (actual); primary completion 2026-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06144125, source copy `cardio:ctgov-nct06144125-2026-06-17`, retrieved 2026-10-26)
- Started: 2026-03-27 (actual) (ClinicalTrials.gov record NCT06144125, source copy `cardio:ctgov-nct06144125-2026-06-17`, retrieved 2026-10-26)
- Primary completion: 2026-09-30 (anticipated) (ClinicalTrials.gov record NCT06144125, source copy `cardio:ctgov-nct06144125-2026-06-17`, retrieved 2026-10-26)
- Completion: 2026-10-30 (anticipated) (ClinicalTrials.gov record NCT06144125, source copy `cardio:ctgov-nct06144125-2026-06-17`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT06144125, source copy `cardio:ctgov-nct06144125-2026-06-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06144125-2026-06-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
- Condition: Cardiac Valve Disease
- Intervention (Biological): fresh frozen plasma
- Intervention (Biological): prothrombin complex concentrate
- Lead sponsor: Konkuk University Medical Center
- Lead sponsor class: OTHER
- Collaborator: Asan Medical Center
- Collaborator class: OTHER
- Collaborator: Soonchunhyang University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as a collaborator: Asan Medical Center (`cardio:org-asan-medical-center`)
- Registry lists this organization as a collaborator: Soonchunhyang University Hospital (`cardio:org-soonchunhyang-university-hospital`)

## Provenance

Content hash: f7fdfd4e800dcc1405770110d43f64baa9ef6f2c8c28b96aa305246f80c02080
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
